SUM.NZ · NZE · Healthcare
Summerset Group Holdings Limited
Also onConsensus Drift
Implied value per share
NZD -9.24
Market price
NZD 7.60
Implied upside
-221.6%
5-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case
Current EV/EBITDA of 118.6x sits outside a defensible 3-20x band, so the exit multiple is capped at 20.0x. A multiple that far out usually means EBITDA is the wrong denominator for this business.
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (NZD). Outflows negative.
| Line | FY26 | FY27 | FY28 | FY29 | FY30 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | NZD 415.2m | NZD 477.7m | NZD 549.5m | NZD 632.2m | NZD 727.4m | +15.0% |
| EBIT | NZD 14.4m | NZD 16.5m | NZD 19.0m | NZD 21.9m | NZD 25.1m | +15.0% |
| NOPAT | NZD 13.7m | NZD 15.8m | NZD 18.1m | NZD 20.9m | NZD 24.0m | +15.0% |
| Add depreciation & amortisation | NZD 25.8m | NZD 29.7m | NZD 34.2m | NZD 39.3m | NZD 45.2m | +15.0% |
| Less capital expenditure | NZD -136.9m | NZD -157.6m | NZD -181.3m | NZD -208.5m | NZD -239.9m | +15.0% |
| Less increase in working capital | NZD -2.0m | NZD -2.3m | NZD -2.6m | NZD -3.0m | NZD -3.4m | +15.0% |
| Free cashflow to firm | NZD -99.4m | NZD -114.3m | NZD -131.5m | NZD -151.3m | NZD -174.1m | -15.0% |
| Discount factor | 0.9710 | 0.9156 | 0.8633 | 0.8140 | 0.7675 | - |
| Present value | NZD -96.5m | NZD -104.7m | NZD -113.6m | NZD -123.2m | NZD -133.6m | -8.5% |
| Present Value Of The Forecast | NZD -571.6m | |||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 4.50% | NZD assumption - no free live source available for this market (assumption) |
| Equity risk premium | 6.50% | Market assumption |
| Beta | 0.528 | Reported 0.295, pulled toward 1.0 (Blume) |
| Cost of equity | 7.93% | Risk-free + beta x equity risk premium |
| Cost of debt | 4.50% | Floored at the risk-free rate (implied cost of debt was lower) |
| Market capitalisation | NZD 1.9bn | 48.4% of capital |
| Total debt | NZD 2.0bn | 51.6% of capital, book value as a proxy |
| Tax rate | 4.5% | Effective, capped at statutory |
| WACC | 6.06% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
-120% of EV
- Forecast FCFF, final year
- NZD -174.1m
- Capex at depreciation, working capital in reinvestment
- NZD 24.0m
- Less reinvestment at g/ROIC (41.3% of NOPAT)
- NZD -9.9m
- Capitalised
- NZD 14.1m
- ROIC (WACC floor)
- 6.1%
- Terminal value, undiscounted
- NZD 406.6m
- Terminal value, discounted
- NZD 312.0m
- Enterprise value
- NZD -259.6m
- Less net debt
- NZD 2.0bn
- Equity value
- NZD -2.2bn
Exit at 20.0x EBITDA
212% of EV
- Terminal value, undiscounted
- NZD 1.4bn
- Terminal value, discounted
- NZD 1.1bn
- Enterprise value
- NZD 508.5m
- Less net debt
- NZD 2.0bn
- Equity value
- NZD -1.5bn
Sensitivity
Value per share (NZD) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 4.06% | -8.57 | -8.56 | -8.55 | -8.54 | -8.53 |
| 5.06% | -8.99 | -8.99 | -8.98 | -8.97 | -8.96 |
| 6.06% | -9.25 | -9.25 | -9.24 | -9.24 | -9.23 |
| 7.06% | -9.42 | -9.42 | -9.41 | -9.41 | -9.40 |
| 8.06% | -9.54 | -9.53 | -9.53 | -9.52 | -9.52 |
Outlined: this model. Green text: above today's price of 7.60. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Model | Implied | Gap |
|---|---|---|---|
| EBIT margin | 3.5% | 39.3% | +35.9pp |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.